|
Thursday, 3 April 2003: 13:30-15:00 |
Room IV (CICG) |
Clinical neurosciences in dementia |
|
| | | | Donepezil-Treated Alzheimer’s Disease Patients Initially Rated as Showing “No Apparent Clinical Benefit” Demonstrate Significant Benefits When Therapy is Continued: Results From a Randomized, Placebo-Controlled Trial
A Kurz, M Barcikowska, S Jakobsen, C Karageorgiou, M Lambert, J McCarthy, M Trixler, CJ Wouters, S Qvitzau, S Richardson, E Schwam, Y Xu, R Schindler, P Johannsen |
| | | | Donepezil in Cognitive Impairment in Parkinson's Disease
Iracema Leroi, Jason Brandt, Stephen G. Reich, Steven Grill, Richard E. Thompson, Laura Marsh |
| | | | Aripiprazole in Dementia of the Alzheimer’s Type
Jacobo Mintzer, Peter De Deyn, Dilip Jeste |
| | | | Acetyl Cholinesterase Inhibitor (AChEI) Use in a UK Old Age Psychiatry Service: Predictors of Response
Sanjeet Pakrasi, Elizabeta Mukaetova-Ladinska, Ian McKeith, John T O'Brien |
| | | | Rivastigmine Efficacy on Behavioral and Psychological
Dana Ignjatovic, Milan Ignjatovič, Željko Tutnjevic |
| | | | Donepezil is Well Tolerated in Patients with Vascular Dementia: A Comparison of Tolerability in Vascular Dementia Patients and Alzheimer’s Disease Patients
Alistair Burns, Raymond D Pratt, Carlos A Perdomo |
| | | | Donepezil Improves Cognition and Global Function in Patients with Vascular Dementia
Alistair Burns, Raymond D Pratt, Carlos A Perdomo |
| | | | White Matter Hyperintensities and Behavioral Disorders in Dementia
Pauline Aalten, Paul Hofman, Jelle Jolles, Frans Verhey, Marjolein De Vugt, Angela Bouwmans |
| | | | Posterior Cortical Atrophy - A series of Ten Cases With PET Findings
Klaus Schmidtke, Michael Hüll, Jochen Talazko |